Institutional Investor Group Discloses $1.95M in Recent Sales Amid Ongoing Distribution
HOWL sits 17% above its 52-week low of $0.27.
Summary
An institutional investor group, MPM BioVentures, disclosed over $1.95 million in recent share sales and intends to sell additional shares, continuing a pattern of distribution from the company.
Key Events · Ownership and Investor Activity · HOWL
-
Proposed Share Sale
MPM BioVentures 2014 (B), L.P. intends to sell 6,459 shares of common stock, valued at approximately $2,198.64.
-
Extensive Recent Sales Disclosed
The filing's attached exhibit details over $1.95 million in sales by related MPM entities between April 27 and June 29, 2026, confirming an ongoing distribution pattern.
-
Significant Institutional Distribution
The cumulative sales by this institutional group represent over 12% of the company's current market capitalization, indicating a substantial reduction in their holdings.
-
Context of Financial Distress
This ongoing institutional selling occurs as the company faces substantial doubt about its ability to continue as a going concern, as disclosed in its last 10-K.
Analysis · HOWL · Life Sciences
This Form 144 filing reveals that a group of related institutional investors, including MPM BioVentures, has sold approximately $1.95 million worth of Werewolf Therapeutics stock over the past three months. This significant distribution, representing over 12% of the company's market capitalization, signals a continued lack of confidence from major shareholders. The ongoing selling by institutional investors is particularly concerning given the company's previously disclosed "going concern" issues and workforce reduction.
At the time of this filing, HOWL was trading at $0.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.6M. The 52-week trading range was $0.27 to $2.38. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.